PMC:7461420 / 87865-88290
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T414 | 233-237 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T415 | 409-413 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1006 | 256-262 | http://purl.obolibrary.org/obo/NCBITaxon_33208 | denotes | animal |
| T1007 | 415-418 | http://purl.obolibrary.org/obo/CLO_0001203 | denotes | 232 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T82363 | 18-28 | Chemical | denotes | interferon | http://purl.obolibrary.org/obo/CHEBI_52999 |
| T93842 | 30-33 | Chemical | denotes | IFN | http://purl.obolibrary.org/obo/CHEBI_52999 |
| T72172 | 94-97 | Chemical | denotes | IFN | http://purl.obolibrary.org/obo/CHEBI_52999 |
| T93598 | 161-164 | Chemical | denotes | IFN | http://purl.obolibrary.org/obo/CHEBI_52999 |
| T11265 | 191-194 | Chemical | denotes | IFN | http://purl.obolibrary.org/obo/CHEBI_52999 |
| T21484 | 336-351 | Chemical | denotes | antiviral drugs | http://purl.obolibrary.org/obo/CHEBI_36044 |
| T39733 | 336-345 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T17520 | 346-351 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T24513 | 357-366 | Chemical | denotes | ribavirin | http://purl.obolibrary.org/obo/CHEBI_63580 |
| T3437 | 376-385 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
| T52636 | 386-395 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T98 | 71-88 | http://purl.obolibrary.org/obo/GO_0019079 | denotes | viral replication |
| T99 | 71-88 | http://purl.obolibrary.org/obo/GO_0019058 | denotes | viral replication |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2705 | 191-203 | Gene | denotes | IFN‐α and ‐β | Gene:3439 |
| 2706 | 243-252 | Species | denotes | MERS‐CoVs | Tax:1335626 |
| 2707 | 179-190 | Species | denotes | recombinant | Tax:575560 |
| 2708 | 357-366 | Chemical | denotes | ribavirin | MESH:D012254 |
| 2709 | 376-395 | Chemical | denotes | lopinavir‐ritonavir | MESH:C558899 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T762 | 0-89 | Sentence | denotes | The host's innate interferon (IFN) response is one key for controlling viral replication. |
| T763 | 90-174 | Sentence | denotes | The IFN response can be increased by administering artificial IFNs and IFN inducers. |
| T764 | 175-270 | Sentence | denotes | The recombinant IFN‐α and ‐β inhibited the replication of SARS‐ and MERS‐CoVs in animal models. |
| T765 | 271-414 | Sentence | denotes | 231 Several studies also described the combination of IFNs with antiviral drugs like ribavirin (180) or lopinavir‐ritonavir for treating SARS. |
| T766 | 415-425 | Sentence | denotes | 232 , 233 |